Licensing

XOMA leverages our 25-year history of leadership in therapeutic antibody discovery as well as our fully integrated product development infrastructure to offer a broad spectrum of collaborative and licensing opportunities. Working with XOMA, or licensing our technologies, makes our partners immediately competitive in therapeutic antibodies - one of the most important modalities for creating new medicines.  XOMA is exceptionally well-positioned to advance product programs, from antibody discovery to regulatory approval, in a seamless, highly coordinated manner.